Advertisement
Screener

INOVIO PHARMACEUTICALS, INC. (INO) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets

INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Prepaid Expense and Other Assets of $628.35 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12

  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.48M, a 8.35% decline year-over-year.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$852.53K.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.99M.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$550.10K.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.11M.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$2.69M.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$39.02M, a 831.20% decline from fiscal 2022.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $5.34M, a 15.88% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$1.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$628.35K
10-Q · filed 2026-08-12
-$1.36M
derived: sum of 3 quarters · filed 2026-08-12
-$1.91M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$852.53K
10-Q · filed 2026-05-13
-$2.84M
derived: sum of 2 quarters · filed 2026-05-13
-$3.39M
derived: sum of 3 quarters · filed 2026-05-13
-$1.77M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$1.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$2.54M
derived: sum of 2 quarters · filed 2026-03-12
-$921.02K
derived: sum of 3 quarters · filed 2026-08-12
-$1.11M
10-K · filed 2026-03-12
2025-09-30-$550.10K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$1.07M
derived: sum of 2 quarters · filed 2026-08-12
$881.07K
10-Q · filed 2025-11-10
-$1.01M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$1.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$1.43M
10-Q · filed 2026-08-12
$1.79M
10-Q · filed 2025-08-12
-$461.42K
derived: sum of 3 quarters · filed 2026-08-12
-$1.21M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$184.62K
10-Q · filed 2026-05-13
-$295.80K
10-Q · filed 2025-05-13
-$2.08M
derived: sum of 2 quarters · filed 2026-05-13
-$2.83M
derived: sum of 3 quarters · filed 2026-05-13
-$977.16K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$1.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$2.64M
derived: sum of 2 quarters · filed 2026-03-12
-$792.55K
derived: sum of 3 quarters · filed 2026-03-12
-$2.69M
10-K · filed 2026-03-12
-$1.48M
10-K · filed 2025-03-18
2024-09-30-$748.74K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$1.10M
derived: sum of 2 quarters · filed 2025-11-10
-$796.98K
10-Q · filed 2025-11-10
-$532.42K
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$1.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$48.24K
10-Q · filed 2025-08-12
$216.33K
derived: sum of 3 quarters · filed 2025-08-12
$2.12M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$1.90M
10-Q · filed 2025-05-13
-$1.63M
derived: sum of 2 quarters · filed 2025-05-13
$274.27K
derived: sum of 3 quarters · filed 2025-05-13
-$1.59M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$264.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$2.17M
derived: sum of 2 quarters · filed 2025-03-18
$303.93K
derived: sum of 3 quarters · filed 2025-03-18
-$39.02M
10-K · filed 2025-03-18
2023-09-30$1.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$39.37K
derived: sum of 2 quarters · filed 2024-11-14
-$39.29M
10-Q · filed 2024-11-14
-$53.09M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$1.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$41.19M
10-Q · filed 2024-08-08
-$55.00M
derived: sum of 3 quarters · filed 2024-08-08
-$53.45M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$39.32M
10-Q · filed 2024-05-13
-$53.13M
derived: sum of 2 quarters · filed 2024-05-13
-$51.58M
derived: sum of 3 quarters · filed 2024-05-13
-$26.91M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$13.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
-$12.25M
derived: sum of 2 quarters · filed 2024-03-06
$12.41M
derived: sum of 3 quarters · filed 2024-03-06
$5.34M
10-K · filed 2024-03-06
2022-09-30$1.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$26.22M
derived: sum of 2 quarters · filed 2023-11-09
$19.15M
10-Q · filed 2023-11-09
-$27.09M
derived: sum of 4 quarters · filed 2024-03-06
2022-06-30$24.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$17.59M
10-Q · filed 2023-08-09
-$28.64M
derived: sum of 3 quarters · filed 2024-03-06
-$28.21M
derived: sum of 4 quarters · filed 2024-03-06
2022-03-31-$7.08M
10-Q · filed 2023-05-10
-$53.31M
derived: sum of 2 quarters · filed 2024-03-06
-$52.87M
derived: sum of 3 quarters · filed 2024-03-06
-$19.84M
derived: sum of 4 quarters · filed 2024-03-06
2021-12-31-$46.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
-$45.80M
derived: sum of 2 quarters · filed 2024-03-06
-$12.76M
derived: sum of 3 quarters · filed 2024-03-06
$6.34M
10-K · filed 2024-03-06
$6.19M
10-K · filed 2022-03-01
2021-09-30$435.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$33.47M
derived: sum of 2 quarters · filed 2022-11-08
$52.58M
10-Q · filed 2022-11-08
$52.68M
10-Q · filed 2021-11-09
$61.00M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$33.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$52.14M
10-Q · filed 2022-08-09
$51.94M
10-Q · filed 2021-08-09
$60.56M
derived: sum of 3 quarters · filed 2023-03-01
$87.53M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$19.11M
10-Q · filed 2022-05-10
$19.21M
10-Q · filed 2021-05-10
$27.53M
derived: sum of 2 quarters · filed 2023-03-01
$54.50M
derived: sum of 3 quarters · filed 2023-03-01
$56.69M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$8.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$35.39M
derived: sum of 2 quarters · filed 2023-03-01
$37.58M
derived: sum of 3 quarters · filed 2023-03-01
$38.48M
10-K · filed 2023-03-01
$38.85M
10-K · filed 2021-03-01
2020-09-30$26.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$29.16M
derived: sum of 2 quarters · filed 2021-11-09
$30.06M
10-Q · filed 2021-11-09
$29.96M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$2.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$3.08M
10-Q · filed 2021-08-09
$2.99M
derived: sum of 3 quarters · filed 2022-03-01
$2.36M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$894.61K
10-Q · filed 2021-05-10
$801.60K
derived: sum of 2 quarters · filed 2022-03-01
$169.84K
derived: sum of 3 quarters · filed 2022-03-01
$1.09M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$93.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$724.76K
derived: sum of 2 quarters · filed 2022-03-01
$197.80K
derived: sum of 3 quarters · filed 2022-03-01
$178.01K
10-K · filed 2022-03-01
2019-09-30-$631.76K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$290.80K
derived: sum of 2 quarters · filed 2020-11-09
$271.01K
10-Q · filed 2020-11-09
$75.74K
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$922.56K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$902.77K
10-Q · filed 2020-08-10
$707.50K
derived: sum of 3 quarters · filed 2021-03-01
$524.28K
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$19.79K
10-Q · filed 2020-05-11
-$215.06K
derived: sum of 2 quarters · filed 2021-03-01
-$398.28K
derived: sum of 3 quarters · filed 2021-03-01
-$615.21K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$195.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$378.49K
derived: sum of 2 quarters · filed 2021-03-01
-$595.42K
derived: sum of 3 quarters · filed 2021-03-01
-$1.19M
10-K · filed 2021-03-01
2018-09-30-$183.22K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$400.16K
derived: sum of 2 quarters · filed 2019-11-12
-$999.05K
10-Q · filed 2019-11-12
-$2.94M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$216.93K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$815.83K
10-Q · filed 2019-08-08
-$2.75M
derived: sum of 3 quarters · filed 2020-03-12
-$3.13M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31-$598.89K
10-Q · filed 2019-05-09
-$2.54M
derived: sum of 2 quarters · filed 2020-03-12
-$2.91M
derived: sum of 3 quarters · filed 2020-03-12
-$2.20M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31-$1.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$2.31M
derived: sum of 2 quarters · filed 2020-03-12
-$1.61M
derived: sum of 3 quarters · filed 2020-03-12
$851.85K
10-K · filed 2020-03-12
2017-09-30-$375.92K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$332.72K
derived: sum of 2 quarters · filed 2018-11-08
$2.79M
10-Q · filed 2018-11-08
$3.15M
derived: sum of 4 quarters · filed 2019-03-12
2017-06-30$708.64K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$3.17M
10-Q · filed 2018-08-07
$3.52M
derived: sum of 3 quarters · filed 2019-03-12
$3.73M
derived: sum of 4 quarters · filed 2019-03-12
2017-03-31$2.46M
10-Q · filed 2018-05-09
$2.81M
derived: sum of 2 quarters · filed 2019-03-12
$3.02M
derived: sum of 3 quarters · filed 2019-03-12
$3.08M
derived: sum of 4 quarters · filed 2019-03-12
2016-12-31$357.81K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$561.02K
derived: sum of 2 quarters · filed 2019-03-12
$626.35K
derived: sum of 3 quarters · filed 2019-03-12
$831.80K
10-K · filed 2019-03-12
2016-09-30$203.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$268.55K
derived: sum of 2 quarters · filed 2017-11-08
$474.00K
10-Q · filed 2017-11-08
$42.36K
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$65.33K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$270.79K
10-Q · filed 2017-08-08
-$160.85K
derived: sum of 3 quarters · filed 2018-03-14
$636.74K
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$205.45K
10-Q · filed 2017-05-10
-$226.18K
derived: sum of 2 quarters · filed 2018-03-14
$571.41K
derived: sum of 3 quarters · filed 2018-03-14
$465.04K
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31-$431.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$365.96K
derived: sum of 2 quarters · filed 2018-03-14
$259.59K
derived: sum of 3 quarters · filed 2018-03-14
$119.28K
10-K · filed 2018-03-14
2015-09-30$797.59K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$691.23K
derived: sum of 2 quarters · filed 2016-11-09
$550.92K
10-Q · filed 2016-11-09
$763.22K
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30-$106.37K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
-$246.68K
10-Q · filed 2016-08-08
-$34.38K
derived: sum of 3 quarters · filed 2017-03-15
-$166.26K
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31-$140.31K
10-Q · filed 2016-05-09
$71.99K
derived: sum of 2 quarters · filed 2017-03-15
-$59.90K
derived: sum of 3 quarters · filed 2017-03-15
$149.90K
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31$212.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
$80.41K
derived: sum of 2 quarters · filed 2017-03-15
$290.21K
derived: sum of 3 quarters · filed 2017-03-15
$160.54K
10-K · filed 2017-03-15
2014-09-30-$131.88K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$77.91K
derived: sum of 2 quarters · filed 2015-11-09
-$51.76K
10-Q · filed 2015-11-09
$113.81K
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30$209.80K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$80.13K
10-Q · filed 2015-08-10
$245.69K
derived: sum of 3 quarters · filed 2016-03-14
$7.27K
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31-$129.67K
10-Q · filed 2015-05-11
$35.90K
derived: sum of 2 quarters · filed 2016-03-14
-$202.53K
derived: sum of 3 quarters · filed 2016-03-14
$288.32K
derived: sum of 4 quarters · filed 2016-03-14
2013-12-31$165.57K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
-$72.86K
derived: sum of 2 quarters · filed 2016-03-14
$417.99K
derived: sum of 3 quarters · filed 2016-03-14
$229.71K
10-K · filed 2016-03-14
2013-09-30-$238.42K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$252.42K
derived: sum of 2 quarters · filed 2014-11-10
$64.14K
10-Q · filed 2014-11-10
-$41.12K
derived: sum of 4 quarters · filed 2015-03-16
2013-06-30$490.85K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$302.56K
10-Q · filed 2014-08-11
$197.31K
derived: sum of 3 quarters · filed 2015-03-16
$86.54K
derived: sum of 4 quarters · filed 2015-03-16
2013-03-31-$188.28K
10-Q · filed 2014-05-12
-$293.54K
derived: sum of 2 quarters · filed 2015-03-16
-$404.30K
derived: sum of 3 quarters · filed 2015-03-16
-$566.55K
derived: sum of 4 quarters · filed 2015-03-16
2012-12-31-$105.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
-$216.02K
derived: sum of 2 quarters · filed 2015-03-16
-$378.27K
derived: sum of 3 quarters · filed 2015-03-16
-$363.58K
10-K · filed 2015-03-16
2012-09-30-$110.76K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$273.01K
derived: sum of 2 quarters · filed 2013-11-12
-$258.33K
10-Q · filed 2013-11-12
-$378.31K
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30-$162.25K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$147.57K
10-Q · filed 2013-08-09
-$267.55K
derived: sum of 3 quarters · filed 2014-03-17
-$223.75K
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31$14.68K
10-Q · filed 2013-05-10
-$105.29K
derived: sum of 2 quarters · filed 2014-03-17
-$61.49K
derived: sum of 3 quarters · filed 2014-03-17
$415.37K
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31-$119.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$76.18K
derived: sum of 2 quarters · filed 2014-03-17
$400.69K
derived: sum of 3 quarters · filed 2014-03-17
$472.07K
10-K · filed 2014-03-17
2011-09-30$43.80K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
$520.66K
derived: sum of 2 quarters · filed 2012-11-07
$592.05K
10-Q · filed 2012-11-07
$552.71K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$476.87K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$548.25K
10-Q · filed 2012-08-09
$508.91K
derived: sum of 3 quarters · filed 2013-03-18
$499.38K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$71.39K
10-Q · filed 2012-05-09
$32.04K
derived: sum of 2 quarters · filed 2013-03-18
$22.51K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$39.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$48.87K
derived: sum of 2 quarters · filed 2013-03-18
-$35.89K
10-K · filed 2013-03-18
2010-09-30-$9.53K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$3.45K
10-Q · filed 2011-11-07
2010-06-30$12.98K
10-Q · filed 2011-08-05
2009-12-31-$242.32K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
MEDICINOVA INC (MNOV)United States$0.130B-6.04
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Immuneering Corp (IMRX)United States$0.113B-12.51